Lincoln Pharmaceuticals to hold 32nd AGM on Sep 30, 2026

Lincoln Pharmaceuticals Ltd. announced that its 32nd Annual General Meeting (AGM) will be held on Wednesday, September 30, 2026, at 11:00 AM IST. The meeting will be conducted through Video Conferencing (VC) or Other Audio-Visual Means (OAVM). Key agenda items include the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026, declaration of a dividend of ₹1.80 per equity share, and the re-appointment of two directors, Mr. Hashmukh I. Patel and Mr. Munjal Mahendrabhai Patel, who are retiring by rotation. Additionally, the members will consider ratifying the remuneration of the cost auditors, Kiran J. Mehta & Co., for ₹2,50,000 per annum plus applicable taxes and expenses.